These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 33601984)

  • 1. Participatory COVID-19 Surveillance Tool in Rural Appalachia : Real-Time Disease Monitoring and Regional Response.
    Runkle JD; Sugg MM; Graham G; Hodge B; March T; Mullendore J; Tove F; Salyers M; Valeika S; Vaughan E
    Public Health Rep; 2021 May; 136(3):327-337. PubMed ID: 33601984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndromic Surveillance Insights from a Symptom Assessment App Before and During COVID-19 Measures in Germany and the United Kingdom: Results From Repeated Cross-Sectional Analyses.
    Mehl A; Bergey F; Cawley C; Gilsdorf A
    JMIR Mhealth Uhealth; 2020 Oct; 8(10):e21364. PubMed ID: 32997640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Self-Reported Symptom Tracking Programs in the United States: Framework Synthesis.
    Koehlmoos TP; Janvrin ML; Korona-Bailey J; Madsen C; Sturdivant R
    J Med Internet Res; 2020 Oct; 22(10):e23297. PubMed ID: 33006943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
    Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
    Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of longitudinal trends in self-reported symptoms and COVID-19 case activity in Ontario, Canada.
    Maharaj AS; Parker J; Hopkins JP; Gournis E; Bogoch II; Rader B; Astley CM; Ivers NM; Hawkins JB; Lee L; Tuite AR; Fisman DN; Brownstein JS; Lapointe-Shaw L
    PLoS One; 2022; 17(1):e0262447. PubMed ID: 35015778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application: a prospective, observational study.
    Varsavsky T; Graham MS; Canas LS; Ganesh S; Capdevila Pujol J; Sudre CH; Murray B; Modat M; Jorge Cardoso M; Astley CM; Drew DA; Nguyen LH; Fall T; Gomez MF; Franks PW; Chan AT; Davies R; Wolf J; Steves CJ; Spector TD; Ourselin S
    Lancet Public Health; 2021 Jan; 6(1):e21-e29. PubMed ID: 33278917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey.
    Pouwels KB; House T; Pritchard E; Robotham JV; Birrell PJ; Gelman A; Vihta KD; Bowers N; Boreham I; Thomas H; Lewis J; Bell I; Bell JI; Newton JN; Farrar J; Diamond I; Benton P; Walker AS;
    Lancet Public Health; 2021 Jan; 6(1):e30-e38. PubMed ID: 33308423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Symptoms of App Users Seeking COVID-19-Related Digital Health Information and Remote Services: Retrospective Cohort Study.
    Perlman A; Vodonos Zilberg A; Bak P; Dreyfuss M; Leventer-Roberts M; Vurembrand Y; Jeffries HE; Fisher E; Steuerman Y; Namir Y; Goldschmidt Y; Souroujon D
    J Med Internet Res; 2020 Oct; 22(10):e23197. PubMed ID: 32961527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Deployment of a Free, Privacy-Assured COVID-19 Symptom Tracker for Public Safety During Reopening: System Development and Feasibility Study.
    Kassaye SG; Spence AB; Lau E; Bridgeland DM; Cederholm J; Dimolitsas S; Smart JC
    JMIR Public Health Surveill; 2020 Aug; 6(3):e19399. PubMed ID: 32788148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internet-based remote health self-checker symptom data as an adjuvant to a national syndromic surveillance system.
    Elliot AJ; Kara EO; Loveridge P; Bawa Z; Morbey RA; Moth M; Large S; Smith GE
    Epidemiol Infect; 2015 Dec; 143(16):3416-22. PubMed ID: 25858297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing COVID-19 surveillance in long-term care facilities: a modelling study.
    Smith DRM; Duval A; Pouwels KB; Guillemot D; Fernandes J; Huynh BT; Temime L; Opatowski L;
    BMC Med; 2020 Dec; 18(1):386. PubMed ID: 33287821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting and Availability of COVID-19 Demographic Data by US Health Departments (April to October 2020): Observational Study.
    Ossom-Williamson P; Williams IM; Kim K; Kindratt TB
    JMIR Public Health Surveill; 2021 Apr; 7(4):e24288. PubMed ID: 33821804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement With the Centers for Disease Control and Prevention Coronavirus Self-Checker and Guidance Provided to Users in the United States From March 23, 2020, to April 19, 2021: Thematic and Trend Analysis.
    Shah AB; Oyegun E; Hampton WB; Neri A; Maddox N; Raso D; Sandhu P; Patel A; Koonin LM; Lee L; Roper L; Whitfield G; Siegel DA; Koumans EH
    J Med Internet Res; 2023 Mar; 25():e39054. PubMed ID: 36745776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minnesota Electronic Health Record Consortium COVID-19 Project: Informing Pandemic Response Through Statewide Collaboration Using Observational Data.
    Winkelman TNA; Margolis KL; Waring S; Bodurtha PJ; Khazanchi R; Gildemeister S; Mink PJ; DeSilva M; Murray AM; Rai N; Sonier J; Neely C; Johnson SG; Chamberlain AM; Yu Y; McFarling LM; Dudley RA; Drawz PE
    Public Health Rep; 2022; 137(2):263-271. PubMed ID: 35060411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participatory Surveillance for COVID-19 Trend Detection in Brazil: Cross-sectional Study.
    Wittwer S; Paolotti D; Lichand G; Leal Neto O
    JMIR Public Health Surveill; 2023 Apr; 9():e44517. PubMed ID: 36888908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use Characteristics and Triage Acuity of a Digital Symptom Checker in a Large Integrated Health System: Population-Based Descriptive Study.
    Morse KE; Ostberg NP; Jones VG; Chan AS
    J Med Internet Res; 2020 Nov; 22(11):e20549. PubMed ID: 33170799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.
    van Dijk WJ; Saadah NH; Numans ME; Aardoom JJ; Bonten TN; Brandjes M; Brust M; le Cessie S; Chavannes NH; Middelburg RA; Rosendaal F; Visser LG; Kiefte-de Jong J
    PLoS One; 2021; 16(6):e0253566. PubMed ID: 34191828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.